GE HealthCare Technologies Inc.
As of Oct 22, 2026, GE HealthCare Technologies is in Stage 1, the basing phase, now in week 12 (since Aug 3, 2026). It closed at $71.42, 18.9% below its 52-week high and above its 200-day average, which is falling.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of pa… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is GEHC early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
GEHC among Medical Devices54th of 141 by relative strength
All 141 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TXG | Stage 2 · wk 48 | 99 | −7.8% |
| 2 | RCEL | Stage 2 · wk 13 | 98 | +40.8% |
| 3 | BFLY | Stage 2 · wk 26 | 98 | −26.0% |
| 4 | HAE | Stage 2 · wk 17 | 96 | +8.7% |
| 5 | GKOS | Stage 2 · wk 25 | 96 | +15.1% |
| 6 | AXGN | Stage 3 · wk 2 | 95 | −15.3% |
| 7 | NEOG | Stage 2 · wk 14 | 95 | −11.7% |
| 8 | BVS | Stage 2 · wk 15 | 95 | +10.5% |
| …54 | GEHC | Stage 1 · wk 12 | 49 | +8.1% |
GE HealthCare Technologies: quick answers
What stage is GE HealthCare Technologies in?
As of Oct 22, 2026, GE HealthCare Technologies (GEHC) is in Stage 1, the basing phase. It entered Stage 1 on Aug 3, 2026 and is in week 12. What the four stages mean
Is GE HealthCare Technologies in an uptrend?
Not yet. GE HealthCare Technologies is in Stage 1, a base that can come before an uptrend. It trades 1.8% above its 200-day average, which is falling.
How far is GE HealthCare Technologies from its 52-week high?
GE HealthCare Technologies closed at $71.42 on Oct 22, 2026, 18.9% below its 52-week high of $88.03. Its 52-week low is $59.45.
How has GE HealthCare Technologies performed over the past year?
As of Oct 22, 2026, GE HealthCare Technologies is down 6.0% over the past year and down 13.6% so far in 2026.
Which sector and industry is GE HealthCare Technologies in?
GE HealthCare Technologies is in the Medical Devices industry, part of the Health Care sector.
About this companyHealth Care· Medical Devices
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.